1 |
Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol 2004;18:631-645.
|
2 |
Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994;120:35-39.
DOI
ScienceOn
|
3 |
Amari W, Zeringue AL, McDonald JR, Caplan L, Eisen SA, Ranganathan P. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis. Rheumatology (Oxford) 2011;50:1431-1439.
DOI
ScienceOn
|
4 |
Kim HS, Cho EA, Bae JM, et al. Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006. J Korean Med Sci 2010;25: 924-929.
DOI
ScienceOn
|
5 |
Park MS, Kim YD, Seo YJ, Lee JH, Park JK. A clinicopathologic study of Bowen's disease. Korean J Dermatol 2003;41:1157-1162.
|
6 |
Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10:R45.
DOI
ScienceOn
|
7 |
Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of antitumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 2009;61:486-504.
DOI
ScienceOn
|
8 |
Askling J, Fored CM, Brandt L, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 2005; 64:1421-1426.
DOI
ScienceOn
|
9 |
Thompson AE, Rieder SW, Pope JE. Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum 2011;63: 1479-1485.
DOI
ScienceOn
|
10 |
Hansen JP, Drake AL, Walling HW. Bowen's Disease: a four-year retrospective review of epidemiology and treatment at a university center. Dermatol Surg 2008;34:878-883.
DOI
ScienceOn
|